US Broker Ratings

Takeda Pharmaceutical Company L (TAK): Investor Outlook with 8.38% Potential Upside and Strong Buy Ratings

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable name in the global healthcare sector, stands as a compelling investment prospect for 2023. With a market capitalization of $54.28 billion, this..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: A Strong Buy with 15.19% Return on Equity and 3.53% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands tall in the biotechnology sector with a market capitalization of $84.42 billion, showcasing its robust presence in the healthcare industry. Based in Tarrytown, New..

GSK plc (GSK) Investor Outlook: Analyzing Growth Prospects in Healthcare with a 3.38% Dividend Yield

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, is a compelling company for investors eyeing the drug manufacturing industry. With a sprawling market cap of $101.84 billion,..

Johnson & Johnson (JNJ) Stock Analysis: Robust Dividend Yield and Promising Growth Potential

Johnson & Johnson (NYSE: JNJ) remains a formidable presence in the healthcare sector, with a market capitalization of $492.44 billion. Its diverse portfolio spans across two main segments: Innovative Medicine..

McKesson Corporation (MCK) Stock Analysis: Revenue Growth and Analyst Optimism Signal Potential Upside

Investors eyeing McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, have reason for optimism as the company continues to demonstrate robust revenue growth and receives strong support from..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A $210 Billion Healthcare Titan with 3.76% Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the medical instruments and supplies industry, continues to captivate investor attention thanks to its innovative approach in healthcare technology. With a market..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential Amid a Robust Revenue Surge

For investors with a keen interest in the healthcare sector, HCA Healthcare, Inc. (NYSE: HCA) presents an intriguing opportunity. With a market capitalization of $110.46 billion, HCA is a major..

UnitedHealth Group (UNH) Stock Analysis: A Compelling 14.5% Upside Potential for Investors

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to capture the attention of investors with its robust growth metrics and promising analyst ratings. With a market..

Merck & Company, Inc. (MRK) Stock Analysis: Investor Outlook with a Promising 2.54% Potential Upside

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to draw investor interest due to its robust product pipeline and strategic partnerships. With a market capitalization..

Oruka Therapeutics, Inc. (ORKA) Stock Analysis: Unpacking a 97.60% Potential Upside in the Biotech Arena

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is catching the attention of investors with its promising pipeline of monoclonal antibody therapeutics targeting inflammatory and immunology (I&I) diseases. Headquartered in Menlo Park, California,..

Rapport Therapeutics, Inc. (RAPP): Investor Outlook with a Promising 84.56% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is capturing investor attention with its impressive 84.56% potential upside, as evidenced by the latest analyst ratings. As a clinical-stage biopharmaceutical company, Rapport Therapeutics is..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 92% Potential Upside in the Medical Technology Sector

AngioDynamics, Inc. (NASDAQ: ANGO), a notable player in the healthcare sector, has caught the attention of investors, not least because of its potential upside of over 92%, as per analyst..

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating a 52-Week High with Strategic Collaborations

Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, specifically within the biotechnology industry, presents a multifaceted proposition to investors. With a market capitalization of $1.61 billion,..

Kamada Ltd. (KMDA) Stock Analysis: Unpacking a 63.52% Potential Upside in Healthcare Innovation

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, is generating buzz among investors due to its compelling potential upside of 63.52%. As a specialist in plasma-derived protein..

Autolus Therapeutics (AUTL): Biotech Stock Poised for a 404% Upside with Strong Buy Ratings

The biotechnology sector often captures investor interest with its potential for groundbreaking medical innovations, and Autolus Therapeutics plc (NASDAQ: AUTL) is no exception. Headquartered in London, this clinical-stage biopharmaceutical company..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Biotech Gem with 148% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is making waves in the biotechnology sector, offering a tantalizing prospect for investors seeking high-growth opportunities in healthcare. With a market capitalization of $822.94 million,..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Deep Dive into Its Healthcare Prospects and Valuation

SIGA Technologies Inc. (NASDAQ: SIGA), a notable player in the healthcare sector, specializes in developing antiviral drugs. With a specific focus on health security, SIGA’s flagship product, TPOXX, is designed..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring the 120% Upside Potential

Investors have been keeping a keen eye on COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotech firm at the forefront of mental health treatment innovation. With a market capitalization of..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Unpacking a 40% Potential Upside

Theravance Biopharma, Inc. (TBPH), a prominent player in the biotechnology sector, is capturing investor attention with its significant potential upside. With a market capitalization of approximately $963.79 million, this South..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Can Investors Expect a 17% Upside?

Cross Country Healthcare, Inc. (NASDAQ: CCRN), a notable player in the healthcare staffing industry, is navigating a challenging landscape marked by fluctuating market conditions and evolving healthcare needs. As an..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds